Skyrizi 600 mg concentrate for solution for infusion
20010
Phase 2 small_molecule active
Quick answer
Skyrizi 600 mg concentrate for solution for infusion for Inflammatory Bowel Disease (IBD) is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Inflammatory Bowel Disease (IBD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active